Management of buprenorphine/naloxone therapy in substances abuse consumers in prison: efficacy and safety by Felice A. Nava

Subjects: Get full text

Healthcare Resource Use and Cost: The Impact of Adopting an Abuse-Deterrent Formulation of Extended Release Morphine by Rossiter LF, Kwong WJ, Marrett E

Subjects: Get full text

Use of a Long-Acting Opioid Microsphere Formulation to Overcome Difficulties in Swallowing Pain Medication by Anderson N, Gillman AG, Wasan AD

Subjects: Get full text

Comparing the effects of decreasing prescription opioid shipments and the release of an abuse deterrent OxyContin formulation on opioid overdose fatalities in WV: an interrupted ti... by Eric W. Lundstrom, Zheng Dai, Caroline P. Groth, Brian Hendricks, Erin L. Winstanley, Marie Abate, Gordon S. Smith

Subjects: Get full text

Managing severe pain and abuse potential: the potential impact of a new abuse-deterrent formulation oxycodone/naltrexone extended-release product by Pergolizzi, J, Pergolizzi, Jr JV, Taylor Jr R, LeQuang JA, Raffa RB

Subjects: Get full text

Determining Abuse Deterrence Performance of Poly (ethylene oxide) Using a Factorial Design by Yogesh Joshi, Srinath Muppalaneni, Alborz Omidian, David Jude Mastropietro, Hamid Omidian

Subjects: “…Abuse deterrent formulation…”
Get full text